Please Wait.....
Report
United States Platelet Rich Plasma Market Report by Product Type (Pure Platelet-Rich Plasma (P-PRP), Leukocyte- and Platelet-Rich Plasma (LPRP), Leukocyte- and Platelet-Rich Fibrin (L-PRF), Pure Platelet-Rich Fibrin (P-PRF)), Origin (Autologous PRP, Homologous PRP, Allogeneic PRP), Application (Orthopedics, Cosmetic Surgery and Dermatology, Neurosurgery, General Surgery, Cardiothoracic Surgery, Urology, Ophthalmology, and Others), End User (Hospitals and Clinics, Research Institutes, and Others), and Region 2024-2032
Market Report I 2024-04-08 I 136 Pages I IMARC Group
The United States platelet rich plasma market size reached US$ 249.6 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 546.2 Million by 2032, exhibiting a growth rate (CAGR) of 8.8% during 2024-2032.
Platelet-rich plasma (PRP) refers to a concentrated plasma protein that contains minor quantities of red blood cells. The platelets are suspended in a small amount of plasma after centrifugation and stimulate healing when injected into the body. PRP is widely administered by non-invasive therapies for long-lasting rejuvenation of ligaments and muscle fibers. Some of the common variants of PRP include pure platelet-rich plasma (P-PRP), leukocyte- and platelet-rich plasma (LPRP), leukocyte- and platelet-rich Fibrin (L-PRF), and pure platelet-rich fibrin (P-PRF).
The rising prevalence of chronic tendon injuries in vital organs is currently bolstering the demand for PRP-based therapies in the US. Furthermore, increasing adoption of effective therapies for treating muscle and acute ligament tearing, arthritis, fractures, orthopedic impairments, etc., is also propelling the market growth. In line with this, the growing awareness towards numerous benefits of PRP treatment in preventing inflammation, encouraging new cartilage formulation, and inducing natural lubrication fluid production, is further augmenting the product demand in the country. Moreover, the rising deployment of advanced healthcare facilities for sports clubs and teams is also catalyzing the adoption of PRP-based therapies for treating common injuries in athletes, such as lumbar spine disc pain, rotator cuff injuries, shoulder pain and instability, tennis/golfer's elbow, etc. Apart from this, the expanding cosmetic surgery sector in the United States is further driving the utilization of PRP-based procedures for improving facial shape and volume. In the coming years, the increasing healthcare expenditures along with the rising demand for non-invasive medical procedures will continue to spur the demand for PRP-based therapies in the United States.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the United States platelet rich plasma market report, along with forecasts at the country level from 2024-2032. Our report has categorized the market based on product type, origin, application, and end user.
Breakup by Product Type:
Pure Platelet-Rich Plasma (P-PRP)
Leukocyte- and Platelet-Rich Plasma (LPRP)
Leukocyte- and Platelet-Rich Fibrin (L-PRF)
Pure Platelet-Rich Fibrin (P-PRF)
Breakup by Origin:
Autologous PRP
Homologous PRP
Allogeneic PRP
Breakup by Application:
Orthopedics
Cosmetic Surgery and Dermatology
Neurosurgery
General Surgery
Cardiothoracic Surgery
Urology
Ophthalmology
Others
Breakup by End User:
Hospitals and Clinics
Research Institutes
Others
Breakup by Region:
Northeast
Midwest
South
West
Competitive Landscape:
The competitive landscape of the industry has also been examined with some of the key players being Arteriocyte Medical Systems Inc. (Isto Technologies II LLC), Arthrex Inc., Depuy Synthes, Inc. (Johnson & Johnson), Dr Prp USA LLC, EmCyte Corporation, Exactech Inc., Glofinn America LLC (Glofinn Co. Ltd.), Regen Lab USA LLC, Stryker Corporation, Terumo BCT Inc. (Terumo Corporation), ThermoGenesis Holdings Inc. and Zimmer Biomet Holdings Inc.
Key Questions Answered in This Report
1. What was the size of the United States platelet rich plasma market in 2023?
2. What is the expected growth rate of the United States platelet rich plasma market during 2024-2032?
3. What are the key factors driving the United States platelet rich plasma market?
4. What has been the impact of COVID-19 on the United States platelet rich plasma market?
5. What is the breakup of the United States platelet rich plasma market based on the product type?
6. What is the breakup of the United States platelet rich plasma market based on the origin?
7. What is the breakup of the United States platelet rich plasma market based on the application?
8. What is the breakup of the United States platelet rich plasma market based on the end user?
9. What are the key regions in the United States platelet rich plasma market?
10. Who are the key players/companies in the United States platelet rich plasma market?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 United States Platelet Rich Plasma Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Product Type
6.1 Pure Platelet-Rich Plasma (P-PRP)
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Leukocyte- and Platelet-Rich Plasma (LPRP)
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Leukocyte- and Platelet-Rich Fibrin (L-PRF)
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Pure Platelet-Rich Fibrin (P-PRF)
6.4.1 Market Trends
6.4.2 Market Forecast
7 Market Breakup by Origin
7.1 Autologous PRP
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Homologous PRP
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Allogeneic PRP
7.3.1 Market Trends
7.3.2 Market Forecast
8 Market Breakup by Application
8.1 Orthopedics
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Cosmetic Surgery and Dermatology
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Neurosurgery
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 General Surgery
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Cardiothoracic Surgery
8.5.1 Market Trends
8.5.2 Market Forecast
8.6 Urology
8.6.1 Market Trends
8.6.2 Market Forecast
8.7 Ophthalmology
8.7.1 Market Trends
8.7.2 Market Forecast
8.8 Others
8.8.1 Market Trends
8.8.2 Market Forecast
9 Market Breakup by End User
9.1 Hospitals and Clinics
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Research Institutes
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Others
9.3.1 Market Trends
9.3.2 Market Forecast
10 Market Breakup by Region
10.1 Northeast
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Midwest
10.2.1 Market Trends
10.2.2 Market Forecast
10.3 South
10.3.1 Market Trends
10.3.2 Market Forecast
10.4 West
10.4.1 Market Trends
10.4.2 Market Forecast
11 SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Arteriocyte Medical Systems Inc. (Isto Technologies II LLC)
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 SWOT Analysis
15.3.2 Arthrex Inc.
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.3 Depuy Synthes Inc. (Johnson & Johnson)
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.3.3 Financials
15.3.4 Dr Prp USA LLC
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.5 EmCyte Corporation
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.6 Exactech Inc.
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.7 Glofinn America LLC (Glofinn Co. Ltd.)
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.8 Regen Lab USA LLC
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.9 Stryker Corporation
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.9.3 Financials
15.3.9.4 SWOT Analysis
15.3.10 Terumo BCT Inc. (Terumo Corporation)
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.10.3 Financials
15.3.10.4 SWOT Analysis
15.3.11 ThermoGenesis Holdings Inc.
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio
15.3.11.3 Financials
15.3.11.4 SWOT Analysis
15.3.12 Zimmer Biomet Holdings Inc.
15.3.12.1 Company Overview
15.3.12.2 Product Portfolio
15.3.12.3 Financials
15.3.12.4 SWOT Analysis
Figure 1: United States: Platelet Rich Plasma Market: Major Drivers and Challenges
Figure 2: United States: Platelet Rich Plasma Market: Sales Value (in Million US$), 2018-2023
Figure 3: United States: Platelet Rich Plasma Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 4: United States: Platelet Rich Plasma Market: Breakup by Product Type (in %), 2023
Figure 5: United States: Platelet Rich Plasma Market: Breakup by Origin (in %), 2023
Figure 6: United States: Platelet Rich Plasma Market: Breakup by Application (in %), 2023
Figure 7: United States: Platelet Rich Plasma Market: Breakup by End User (in %), 2023
Figure 8: United States: Platelet Rich Plasma Market: Breakup by Region (in %), 2023
Figure 9: United States: Platelet Rich Plasma (Pure Platelet-Rich Plasma (P-PRP)) Market: Sales Value (in Million US$), 2018 & 2023
Figure 10: United States: Platelet Rich Plasma (Pure Platelet-Rich Plasma (P-PRP)) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 11: United States: Platelet Rich Plasma (Leukocyte- and Platelet-Rich Plasma (LPRP)) Market: Sales Value (in Million US$), 2018 & 2023
Figure 12: United States: Platelet Rich Plasma (Leukocyte- and Platelet-Rich Plasma (LPRP)) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 13: United States: Platelet Rich Plasma (Leukocyte- and Platelet-Rich Fibrin (L-PRF) ) Market: Sales Value (in Million US$), 2018 & 2023
Figure 14: United States: Platelet Rich Plasma (Leukocyte- and Platelet-Rich Fibrin (L-PRF) ) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 15: United States: Platelet Rich Plasma (Pure Platelet-Rich Fibrin (P-PRF)) Market: Sales Value (in Million US$), 2018 & 2023
Figure 16: United States: Platelet Rich Plasma (Pure Platelet-Rich Fibrin (P-PRF)) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 17: United States: Platelet Rich Plasma (Autologous PRP) Market: Sales Value (in Million US$), 2018 & 2023
Figure 18: United States: Platelet Rich Plasma (Autologous PRP) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 19: United States: Platelet Rich Plasma (Homologous PRP) Market: Sales Value (in Million US$), 2018 & 2023
Figure 20: United States: Platelet Rich Plasma (Homologous PRP) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 21: United States: Platelet Rich Plasma (Allogeneic PRP) Market: Sales Value (in Million US$), 2018 & 2023
Figure 22: United States: Platelet Rich Plasma (Allogeneic PRP) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 23: United States: Platelet Rich Plasma (Orthopedics) Market: Sales Value (in Million US$), 2018 & 2023
Figure 24: United States: Platelet Rich Plasma (Orthopedics) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 25: United States: Platelet Rich Plasma (Cosmetic Surgery and Dermatology) Market: Sales Value (in Million US$), 2018 & 2023
Figure 26: United States: Platelet Rich Plasma (Cosmetic Surgery and Dermatology) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 27: United States: Platelet Rich Plasma (Neurosurgery) Market: Sales Value (in Million US$), 2018 & 2023
Figure 28: United States: Platelet Rich Plasma (Neurosurgery) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 29: United States: Platelet Rich Plasma (General Surgery) Market: Sales Value (in Million US$), 2018 & 2023
Figure 30: United States: Platelet Rich Plasma (General Surgery) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 31: United States: Platelet Rich Plasma (Cardiothoracic Surgery) Market: Sales Value (in Million US$), 2018 & 2023
Figure 32: United States: Platelet Rich Plasma (Cardiothoracic Surgery) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 33: United States: Platelet Rich Plasma (Urology) Market: Sales Value (in Million US$), 2018 & 2023
Figure 34: United States: Platelet Rich Plasma (Urology) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 35: United States: Platelet Rich Plasma (Ophthalmology) Market: Sales Value (in Million US$), 2018 & 2023
Figure 36: United States: Platelet Rich Plasma (Ophthalmology) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 37: United States: Platelet Rich Plasma (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
Figure 38: United States: Platelet Rich Plasma (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 39: United States: Platelet Rich Plasma (Hospitals and Clinics) Market: Sales Value (in Million US$), 2018 & 2023
Figure 40: United States: Platelet Rich Plasma (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 41: United States: Platelet Rich Plasma (Research Institutes) Market: Sales Value (in Million US$), 2018 & 2023
Figure 42: United States: Platelet Rich Plasma (Research Institutes) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 43: United States: Platelet Rich Plasma (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
Figure 44: United States: Platelet Rich Plasma (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 45: Northeast: Platelet Rich Plasma Market: Sales Value (in Million US$), 2018 & 2023
Figure 46: Northeast: Platelet Rich Plasma Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 47: Midwest: Platelet Rich Plasma Market: Sales Value (in Million US$), 2018 & 2023
Figure 48: Midwest: Platelet Rich Plasma Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 49: South: Platelet Rich Plasma Market: Sales Value (in Million US$), 2018 & 2023
Figure 50: South: Platelet Rich Plasma Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 51: West: Platelet Rich Plasma Market: Sales Value (in Million US$), 2018 & 2023
Figure 52: West: Platelet Rich Plasma Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 53: United States: Platelet Rich Plasma Industry: SWOT Analysis
Figure 54: United States: Platelet Rich Plasma Industry: Value Chain Analysis
Figure 55: United States: Platelet Rich Plasma Industry: Porter's Five Forces Analysis
Table 1: United States: Platelet Rich Plasma Market: Key Industry Highlights, 2023 and 2032
Table 2: United States: Platelet Rich Plasma Market Forecast: Breakup by Product Type (in Million US$), 2024-2032
Table 3: United States: Platelet Rich Plasma Market Forecast: Breakup by Origin (in Million US$), 2024-2032
Table 4: United States: Platelet Rich Plasma Market Forecast: Breakup by Application (in Million US$), 2024-2032
Table 5: United States: Platelet Rich Plasma Market Forecast: Breakup by End User (in Million US$), 2024-2032
Table 6: United States: Platelet Rich Plasma Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 7: United States: Platelet Rich Plasma Market: Competitive Structure
Table 8: United States: Platelet Rich Plasma Market: Key Players
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security